
ABOUT AJINOMOTO BIO-PHARMA SERVICES
Ajinomoto Bio-Pharma Services is a fully integrated contract development and manufacturing organization, with sites in Belgium, United States, Japan and India, providing comprehensive process development services, cGMP manufacturing and drug product fill finish services of small molecule and biologic APIs and intermediates. We offer a broad range of innovative platforms and capabilities to rapidly scale from clinical and pilot programs to commercial quantities, including: Corynex protein expression technology, oligonucleotide synthesis, antibody drug conjugations (ADC), high potency APIs (HPAPI), biocatalysis, continuous flow manufacturing and more. Ajinomoto Bio-Pharma Services is dedicated to providing a high level of quality and service to meet our clients’ needs.
Ajinomoto Bio-Pharma Services offers a range capabilities through its facilities around the world. Our facilities in Belgium, Japan, and India focus on conventional small molecule API and intermediate production. The focus at our California, USA facility is on large molecule and ADC manufacturing and aseptic fill finish services. Our Osaka, Japan facilities focus on oligonucleotide synthesis.
Our expertise and extensive knowledge of international requirements help assure your product will meet the highest possible quality standards. Our goal is to deliver quality product and personalized service, while providing flexibility and guidance to help our clients achieve their goals in a timely and efficient, cost-effective manner.
Ajinomoto Bio-Pharma Services is a member of the Ajinomoto Group companies, a global company focused on the research, development, and manufacture of high quality products for the pharmaceutical, specialty chemical, nutraceutical, sports nutrition, and health & beauty industries, as well as food seasonings and consumer food products.
AJINOMOTO VIDEOS
-
Fully Integrated CDMO Services To Improve The Health Of Humankind
Your programs deserve the most comprehensive suite of CDMO services available, and Ajinomoto Bio-Pharma Services has the Power To Make your therapeutic vision a reality — from pre-clinical through commercial production.
-
Ajinomoto Bio-Pharma Services - Let's Make A Global Difference
In this video, President and CEO David Enloe explains why the company is focused on serving their clients, patients, and the power to make peoples lives better along with further insights from other key executives.
CONTACT INFORMATION
Ajinomoto Bio-Pharma Services
11040 Roselle Street
San Diego, CA 92121
UNITED STATES
Phone: 858-882-0123
Fax: 858-839-7329
SERVICES
BROCHURES
- Ajinomoto Drug Product Fill Finish Capabilities
- Possibilities For Streamlining Drug Product Manufacturing
- AJILITY™ Platform - Streamline Your Drug Product Manufacturing Program
- Fill Finish Capabilities: COVID-19
- Oligos And Peptides - A Seamless Supply From Research To Commercial Scale
- Ajinomoto Bio-Pharma Services Simplified ADC Supply Chain
- Ajinomoto Bio-Pharma Services Capabilities Brochure
FEATURED ARTICLES
- Ajinomoto Bio-Pharma Services And Revance Therapeutics Announce Manufacturing Agreement For Supply Of DaxibotulinumtoxinA For Injection
- Assure Scalability, Overcome Regulatory Hurdles & Speed Time To Clinic
- First Commercial Drug Manufactured Via Ajinomoto Bio-Pharma Services’ AJIPHASE Technology Receives FDA Approval
- Ajinomoto Bio-Pharma Services Introduces AJILITY Fast Track Platform For Drug Product Manufacturing
- Oligonucleotide Therapeutics: Partnering With The Right CDMO
- Ajinomoto Bio-Pharma Services Completes Acquisition Of Granules OmniChem Joint Venture In India
- Ajinomoto Bio-Pharma Services Signs Manufacturing Agreement with Humanigen for Lenzilumab, Currently in FDA-Approved Phase III Study for COVID-19
- Ajinomoto Bio-Pharma Services Announces Manufacturing Partnership With CytoDyn For Drug Product Used In COVID-19 Clinical Trials
- From Research To Commercial: A Seamless Supply Of Oligonucleotides
- Are You Protecting Your Employees During HPAPI Manufacturing?
- A GMP Strategy For ADC Synthesis Using Site-Specific Chemical Conjugation
- Continuous Flow Manufacturing Of Pharmaceutical Ingredients
- ADC Development And Manufacturing Capabilities With AJICAP™ Technology
- Evolution of AJICAP™ Technology
- Critical Factors Of Fill Finish Manufacturing For Large Molecules
- Is Your Complex Formulation Process Set Up For Success?
- Preparing For Your CDMO Selection Process
- Component Selection: The Key To Your Program Success
- 5 ADC Manufacturing Challenges You Need To Know
- Corynex Protein Expression: Simplifying Recombinant Protein Production